Ten-Year Results Find that Bypass Lowers the Odds of Cardiovascular Death
April 14, 2016
NEW YORK (Reuters Health) - Ten-year results from a comparison of coronary-artery bypass grafting (CABG) with medical therapy alone has found that bypass lowers the odds of cardiovascular death by about nine percentage points in people with ischemic cardiomyopathy. The 16% reduction in the death
Study Shows Non-diabetics can Benefit from Taking the Diabetes Drug Pioglitaztione
March 1, 2016
NEW YORK (Reuters Health) - The diabetes drug pioglitazone, given to non-diabetics with a recent history of stroke or transient ischemic attack (TIA), prevented subsequent strokes and reduced their odds of developing type 2 diabetes, a long-term multicenter study has concluded. But the drug also
Younger Type 2 Diabetics Face Greater Mortality Risks
November 11, 2015
NEW YORK - People with type 2 diabetes are 15 percent more likely to die from any cause and 14 percent more likely to die from a cardiovascular cause than non-diabetics at any given time, according to data from several Swedish registries. The rates are significantly lower than previous estimates.
New Studies Find RIPC Ineffective
November 4, 2015
NEW YORK - The theory that heart surgery can be made safer by periodically cutting off blood flow to an arm has been called into serious question. Two large randomized studies, published online by the New England Journal of Medicine and presented on Oct.
Troponin Test Can Predict Mortality Risk in Cardiovascular Patients
September 11, 2015
NEW YORK — An experimental, highly sensitive troponin test cannot predict when type 2 diabetics with stable ischemic heart disease will benefit from prompt coronary revascularization, but it can show which patients are more likely to die from myocardial infarction, stroke, or other cardiovascular ca